Prevalence of antimicrobial resistance and association with toxin genes in Clostridium difficile in commercial swine

American Journal of Veterinary Research

Volumn 71, Issue 10, 2010, Pages 1189-1194

  Thakur, Siddhartha ^a   Putnam, Michelle ^a   Fry, Pamela R ^b   Abley, Melanie ^b   Gebreyes, Wondwossen A ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL TOXIN; CIPROFLOXACIN; CLOSTRIDIUM DIFFICILE BINARY TOXIN; CLOSTRIDIUM DIFFICILE CYTOTOXIN B; CLOSTRIDIUM DIFFICILE ENTEROTOXIN A; ERYTHROMYCIN; METRONIDAZOLE; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMERCIAL SPECIES; FECES ANALYSIS; FEMALE; FOOD SAFETY; INFECTION RATE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; SOW (SWINE); SWINE; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; MALE; MICROBIAL SENSITIVITY TESTS; SWINE; SWINE DISEASES;

ANIMALIA; CLOSTRIDIUM DIFFICILE; SUIDAE;

EID: 77958586199     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.10.1189     Document Type: Article

References (38)

1. Cookson B. Hypervirulent strains of Clostridium difficile. Postgrad Med J 2007;83:291-295.
2. Debast SB, van Leengoed LA, Goorhuis A, et al. Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environ Microbiol 2009;11:505-511.
3. Razavi B, Apisarnthanarak A, Mundy LM. Clostridium difficile: emergence of hyperviluence and fluoroquinolone resistance. Infection 2007;35:300-307. (Pubitemid 47502344)
4. Riley TV. Epidemic Clostridium difficile. Med J Aust 2006;185:133-134.
5. Baverud V, Gustafsson A, Franklin A, et al. Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. Equine Vet J 2003;35:465-471. (Pubitemid 38698708)
6. Songer JG, Uzal FA. Clostridial enteric infections in pigs. J Vet Diagn Invest 2005;17:528-536.
7. Songer JG, Anderson MA. Clostridium difficile: an important pathogen of food animals. Anaerobe 2006;12:1-4.
8. Hammitt MC, Bueschel DM, Keel MK, et al. A possible role for Clostridium difficile in the etiology of calf enteritis. Vet Microbiol 2008;127:343-352.
9. Rodriguez-Palacios A, Staempfli HR, Duffield T, et al. Clostridium difficile in retail ground meat, Canada. Emerg Infect Dis 2007;13:485-487. (Pubitemid 46348139)
10. Goorhuis A, Debast SB, van Leengoed LA, et al. Clostridium difficile PCR ribotype078: an emerging strain in humans and in pigs? (lett) J Clin Microbiol 2008;46:1157.
11. Keel K, Brazier JS, Post KW, et al. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 2007;45:1963-1964. (Pubitemid 46933933)
12. Indra A, Lassnig H, Baliko N, et al. Clostridium difficile: a new zoonotic agent? Wien Klin Wochenschr 2009;121:91-95.
13. Jhung MA, Thompson AD, Killgore GE, et al. Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 2008;14:1039-1045. (Pubitemid 351920432)
14. Rupnik M, Widmer A, Zimmermann O, et al. Clostridium difficile toxinotype V, ribotype 078, in animals and humans (lett). J Clin Microbiol 2008;46:2146.
15. Songer JG. Infection of neonatal swine with Clostridium difficile. Swine Health Prod 2000;8:185-189.
16. Lemee L, Dhalluin A, Testelin S, et al. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol 2004;42:5710-5714. (Pubitemid 39664357)
17. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. CLSI document M11-A7. Wayne, Pa: Clinical and Laboratory Standards Institute, 2007.
18. Zheng L, Citron DM, Genheimer CW, et al. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates. Anaerobe 2007;13:114-120.
19. Stubbs S, Rupnik M, Gibert M, et al. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000;186:307-312.
20. Post KW, Jost BH, Songer JG. Evaluation of a test for Clostridium difficile toxins A and B for the diagnosis of neonatal swine enteritis. J Vet Diagn Invest 2002;14:258-259.
21. Alvarez-Perez S, Blanco JL, Bouza E, et al. Prevalence of Clostridium difficile in diarrhoeic and non-diarrhoeic piglets. Vet Microbiol 2009;137:302-305.
22. Viscidi R, Laughon BE, Yolken R, et al. Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983;148:93-100.
23. Giesemann T, Guttenberg G, Aktories K. Human alpha-defensins inhibit Clostridium difficile toxin B. Gastroenterology 2008;134:2049-2058. (Pubitemid 351783267)
24. Brazier JS, Raybould R, Patel B, et al. Distribution and antimicrobial susceptibility patterns of Clostridium difficile PCR ribotypes in English hospitals, 2007-08. Euro Surveill [serial online] 2008;13. Available at: www.eurosurveillance.org/viewarticle.aspx?articleid=19000. Accessed Apr 8, 2009.
25. Schmidt C, Löffler B, Ackermann G. Antimicrobial phenotypes and molecular basis in clinical strains of Clostridium difficile. Diagn Microbiol Infect Dis 2007;59:1-5.
26. Post KW, Songer JG. Antimicrobial susceptibility of Clostridium difficile isolated from neonatal pigs with enteritis. Anaerobe 2004;10:47-50. (Pubitemid 38368887)
27. Wilkins TD, Lyerly DM. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 2003;41:531-534.
28. Moncrief JS, Zheng L, Neville LM, et al. Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR. J Clin Microbiol 2000;38:3072-3075. (Pubitemid 30640601)
29. Drudy D, Harnedy N, Fanning S, et al. Isolation and characterization of toxin A negative, toxin B-positive Clostridium difficile in Dublin, Ireland. Clin Microbiol Infect 2007;13:298-304. (Pubitemid 46603361)
30. Drudy D, Quinn T, O'Mahony R, et al. High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostri dium difficile. J Antimicrob Chemother 2006;58:1264-1267. (Pubitemid 44884150)
31. Rupnik M, Kato N, Grabnar M, et al. New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia. J Clin Microbiol 2003;41:1118-1125. (Pubitemid 36307116)
32. Shin BM, Kuak EY, Yoo HM, et al. Multicentre study of the prevalence of toxingenic Clostridium difficile in Korea: results of a retrospective study 2000-2005. J Med Microbiol 2008;57:697-701.
33. Rupnik M. Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease? Clin Microbiol Infect 2007;13:457-459.
34. Terhes G, Urbán E, Sóki J, et al. Community-acquired Clostridium difficile diarrhea cause by binary toxin, toxin A, and toxin B gene-positive isolates in Hungary. J Clin Microbiol 2004;42:4316-4318.
35. Barbut F, Decre D, Lalande V, et al. Clinical features of Clostridium difficile associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005;54:181-185.
36. Rosengren LB, Waldner CL, Reid-Smith RJ, et al. Associations between antimicrobial exposure and resistance in fecal Campylobacter species from grow-finish pigs on-farm in Alberta and Saskatchewan, Canada. J Food Prot 2009;72:482-489.
37. McGowan-Spicer LL, Fedorka-Cray PJ, Frye JG, et al. Antimicrobial resistance and virulence of Enterococcus faecalis isolated from retail food. J Food Prot 2008;71:760-769.
38. Boerlin P, Travis R, Gyles CL, et al. Antimicrobial resistance and virulence genes of Escherichia coli isolates from swine in Ontario. Appl Environ Microbiol 2005;71:6753-6761.